FindTrial
Sign In

Importance of Homoeopathy in management of Gout

A clinical study to assess the predominancy of sycotic miasm in case of gout with effectiveness of anti-sycotic homoeopathic medicine - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095479
Enrollment
40
Registered
2025-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine will be administered in 30, 200, 1m potencies at the interval of 7 days to 15 days Control Intervention1: Plac

Sponsors

Rajkot Homoeopathic Medical College
Lead Sponsor
Sainath Homoeopathic Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: NIL

Exclusion criteria

Exclusion criteria: Presence of serious comorbidities (e.g., malignancy, uncontrolled diabetes, severe cardiac disease)

Design outcomes

Primary

MeasureTime frame
To evaluate the predominance of the sycotic miasm in cases of goutTimepoint: Within 8 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Bibhu Prasad Panda

Rajkot Homoeopathic Medical College

bprasadpanda@gmail.com9687657405

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026